SCHEDULE 13G/A: Brown Capital Management Discloses 7.77% Stake in OrthoPediatrics Corp.
Beneficial Ownership Report
Brown Capital Management, LLC has filed an amended Schedule 13G, reporting a beneficial ownership of 7.77% of OrthoPediatrics Corp.'s Class A common stock as of December 31, 2024.
Summary
- Brown Capital Management, LLC reported beneficial ownership of 1,882,405 shares of OrthoPediatrics Corp. Class A common stock.
- This represents 7.77% of the total Class A common stock outstanding.
- The filing is an Amendment No. 8 to a previous Schedule 13G, indicating an update to an existing position.
- Brown Capital Management, LLC holds sole voting power over 1,002,044 shares and sole dispositive power over all 1,882,405 shares.
- The shares are held on behalf of various investment advisory clients, with Brown Capital Management exercising discretionary investment and/or voting power.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of OrthoPediatrics Corp.
Sentiment
Score: 5
Explanation: The document is a neutral, factual disclosure of beneficial ownership by an institutional investor, providing no positive or negative sentiment regarding the company's performance or prospects.
Positives
- NA This filing is a beneficial ownership disclosure and does not contain information on company performance or operational positives.
Negatives
- NA This filing is a beneficial ownership disclosure and does not contain information on company performance or operational negatives.
Risks
- NA This filing is a beneficial ownership disclosure and does not detail company-specific risks.
Management Comments
- NA This filing is a beneficial ownership disclosure and does not contain management comments beyond the certification statement.
Comparison to Industry Standards
- NA This filing is a beneficial ownership disclosure and does not provide comparative analysis.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
Legal Proceedings
- NA This filing is a beneficial ownership disclosure and does not report legal proceedings.
Related Party Transactions
- NA This filing is a beneficial ownership disclosure and does not report related party transactions.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional ownership stake in OrthoPediatrics Corp., indicating continued investment interest from Brown Capital Management, LLC.
Next Steps
- NA This filing is a disclosure of past ownership and does not outline future actions or milestones for the company or the reporting entity.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event requiring the filing of this statement, reflecting the beneficial ownership position. |
| 05/15/2025 | Date the Schedule 13G/A filing was signed by Brown Capital Management, LLC. |
Keywords
OrthoPediatrics Corp., Brown Capital Management, Schedule 13G, Beneficial Ownership, Class A Common Stock, Institutional Investor, SEC Filing, Medical Devices, Pediatric Orthopedics
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.